Skip to main content

ESTUDIO DE LOS MECANISMOS Y TRASCENDENCIA IN VIVO DE LAS ALTERACIONES DEL TRAFICO INTRACELULAR DE LIPIDOS INDUCIDAS POR XENOBIOTICOS Y SU PREVENCION POR POLIFENOLES

SAF2015-70747-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Postprandial Circulating miRNAs in Response to a Dietary Fat Challenge

  • Mantilla-Escalante, Diana C.
  • López de las Hazas Mingo, María del Carmen
  • Gil-Zamorano, Judit
  • Pozo-Acebo, Lorena del
  • Crespo, M. Carmen
  • Martín-Hernández, Roberto
  • Saz, Andrea del
  • Tomé-Carneiro, Joao
  • Cardona, Fernando
  • Cornejo-Pareja, Isabel
  • García-Ruiz, Almudena
  • Briand, Olivier
  • Lasunción Ripa, Miguel Ángel
  • Visioli, F. (Francesco)
  • Dávalos, Alberto
Postprandial lipemia has many physiopathological effects, some of which increase the risk of cardiovascular disease. MicroRNAs (miRNAs) can be found in almost all biological fluids, but their postprandial kinetics are poorly described. We aimed to profile circulating miRNAs in response to a fat challenge. In total, 641 circulating miRNAs were assessed by real-time PCR in plasmas from mice two hours after lipid gavage. Mice with intestine-specific loss of Dicer were screened to identify potential miRNAs released by the intestine. A total of 68 miRNAs were selected for further validation. Ten circulating miRNAs were finally validated as responsive to postprandial lipemia, including miR-206-3p, miR-543-3p, miR-466c-5p, miR-27b-5p, miR-409-3p, miR-340-3p, miR-1941-3p, miR-10a-3p, miR-125a-3p, and miR-468-3p. Analysis of their possible tissues of origin/target showed an enrichment of selected miRNAs in liver, intestine, brain, or skeletal muscle. miR-206, miR-27b-5p, and miR-409-3p were validated in healthy humans. Analysis of their predicted target genes revealed their potential involvement in insulin/insulin like growth factor (insulin/IGF), angiogenesis, cholecystokinin B receptor signaling pathway (CCKR), inflammation or Wnt pathways for mice, and in platelet derived growth factor (PDGF) and CCKR signaling pathways for humans. Therefore, the current study shows that certain miRNAs are released in the circulation in response to fatty meals, proposing them as potential novel therapeutic targets of lipid metabolism., This research was funded by grants from the Fundación Ramón Areces (CIVP18A3888) to A.D., F.V., J.T.-C., M.C.C., J.G.-Z. and R.M.-H.; by the Spanish “Agencia Estatal de Investigación” to A.D. and R.M.-H. (AGL2016-78922-R) and to M.A.L. (SAF2015-70747-R). Also supported by Fondo Europeo de Desarrollo Regional (FEDER) European funds. This research was also supported by the Nicolas Monardes program (C-0032-2016) from Consejería de Salud, co-funded by FEDER European funds (Madrid, Spain) to F.C. Also supported by grant PI17/01104 from the Instituto de Salud Carlos III to F. C.; and partly funded by POR FESR 3S4H to F.V. D.C.M.-E. is a fellow of “Centro de Estudios Interdisciplinarios Básicos y Aplicados” (CEIBA), Colombia, through the program “Bolívar Gana con Ciencia”. M.-C.L.d.l.H and L.d.P.-A were recipients of a contract supported by Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid, Fondo Social Europeo, and Iniciativa de Empleo Juvenil YEI (PEJD-2016/BIO-2781 and PEJD-2017-PRE/BIO-5100, respectively). A.G.-R. acknowledges the Marie Curie AMAROUT-II Europe Program (Grant Agreement No. 291803). We would also like to thank the COST Action CA16120 Epitran for networking.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1

  • González-Ramos, Silvia
  • Paz-García, Marta
  • Rius, Cristina
  • Monte-Monge, Alberto del
  • Rodríguez-Sinovas, Cristina
  • Fernández-García, Victoria
  • Andrés, Vicente
  • Martínez-González, José
  • Lasunción, Miguel A.
  • Martín-Sanz, Paloma
  • Soehnlein, Oliver
  • Boscá, Lisardo
Atherosclerosis is a chronic disease characterized by vascular lipid retention and inflammation, and pattern recognition receptors (PRRs) are important contributors in early stages of the disease. Given the implication of the intracellular PRR nucleotide-binding oligomerization domain 1 (NOD1) in cardiovascular diseases, we investigated its contribution to early atherosclerosis. We evidenced NOD1 induction in atherosclerotic human and mouse tissues, predominantly in vascular endothelial cells. Accordingly, NOD1 genetic inactivation in Apoe-/- mice reduced not only atherosclerosis burden, but also monocyte and neutrophil accumulation in atheromata. Of note, in the presence of either peptidoglycan or oxidized LDLs, endothelial NOD1 triggered VCAM-1 up-regulation through the RIP2-NF-¿B axis in an autocrine manner, enhancing firm adhesion of both sets of myeloid cells to the inflamed micro- and macrovasculature in vivo. Our data define a major proatherogenic role for endothelial NOD1 in early leukocyte recruitment to the athero-prone vasculature, thus introducing NOD1 as an innovative therapeutic target and potential prognostic molecule, This work was supported bythe the Ministry of Science, Innovation and Universities(Grants SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1), the Center for Biomedical Research Network Consortium in Cardiovascular Diseases (Grants CB16/11/00257, CB16/11/00405, CB/11/00222), Community of Madrid Grant BMD/3686, the German Research Foundation (Grants SFB914 TPA02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01), and the Netherlands Organization for Scientific Research (VIDI proj-ect 91712303). This project was also financed, in part, by theEuropean Regional Development Fund. O.S. and L.B. con-tributed equally as senior authors.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Postprandial Circulating miRNAs in Response to a Dietary Fat Challenge

  • Mantilla-Escalante, Diana C.
  • López de las Hazas Mingo, María del Carmen
  • Gil-Zamorano, Judit
  • Pozo-Acebo, Lorena del
  • Crespo, M. Carmen
  • Martín-Hernández, Roberto
  • Saz, Andrea del
  • Tomé-Carneiro, Joao
  • Cardona, Fernando
  • Cornejo-Pareja, Isabel
  • García-Ruiz, Almudena
  • Briand, Olivier
  • Lasunción Ripa, Miguel Ángel
  • Visioli, F. (Francesco)
  • Dávalos, Alberto
Postprandial lipemia has many physiopathological effects, some of which increase the risk of cardiovascular disease. MicroRNAs (miRNAs) can be found in almost all biological fluids, but their postprandial kinetics are poorly described. We aimed to profile circulating miRNAs in response to a fat challenge. In total, 641 circulating miRNAs were assessed by real-time PCR in plasmas from mice two hours after lipid gavage. Mice with intestine-specific loss of Dicer were screened to identify potential miRNAs released by the intestine. A total of 68 miRNAs were selected for further validation. Ten circulating miRNAs were finally validated as responsive to postprandial lipemia, including miR-206-3p, miR-543-3p, miR-466c-5p, miR-27b-5p, miR-409-3p, miR-340-3p, miR-1941-3p, miR-10a-3p, miR-125a-3p, and miR-468-3p. Analysis of their possible tissues of origin/target showed an enrichment of selected miRNAs in liver, intestine, brain, or skeletal muscle. miR-206, miR-27b-5p, and miR-409-3p were validated in healthy humans. Analysis of their predicted target genes revealed their potential involvement in insulin/insulin like growth factor (insulin/IGF), angiogenesis, cholecystokinin B receptor signaling pathway (CCKR), inflammation or Wnt pathways for mice, and in platelet derived growth factor (PDGF) and CCKR signaling pathways for humans. Therefore, the current study shows that certain miRNAs are released in the circulation in response to fatty meals, proposing them as potential novel therapeutic targets of lipid metabolism., This research was funded by grants from the Fundación Ramón Areces (CIVP18A3888) to A.D., F.V., J.T.-C., M.C.C., J.G.-Z. and R.M.-H.; by the Spanish “Agencia Estatal de Investigación” to A.D. and R.M.-H. (AGL2016-78922-R) and to M.A.L. (SAF2015-70747-R). Also supported by Fondo Europeo de Desarrollo Regional (FEDER) European funds. This research was also supported by the Nicolas Monardes program (C-0032-2016) from Consejería de Salud, co-funded by FEDER European funds (Madrid, Spain) to F.C. Also supported by grant PI17/01104 from the Instituto de Salud Carlos III to F. C.; and partly funded by POR FESR 3S4H to F.V. D.C.M.-E. is a fellow of “Centro de Estudios Interdisciplinarios Básicos y Aplicados” (CEIBA), Colombia, through the program “Bolívar Gana con Ciencia”. M.-C.L.d.l.H and L.d.P.-A were recipients of a contract supported by Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid, Fondo Social Europeo, and Iniciativa de Empleo Juvenil YEI (PEJD-2016/BIO-2781 and PEJD-2017-PRE/BIO-5100, respectively). A.G.-R. acknowledges the Marie Curie AMAROUT-II Europe Program (Grant Agreement No. 291803). We would also like to thank the COST Action CA16120 Epitran for networking.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport

  • Fernández-Suárez, María E.|||0000-0003-4277-2079
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Pastor, Oscar|||0000-0002-4368-433X
  • Dávalos, Alberto
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Lasunción, Miguel A.|||0000-0003-0299-9391
  • Martínez-Botas, Javier|||0000-0002-5190-3619
  • Gómez-Coronado, Diego|||0000-0002-8382-3920
Selective estrogen receptor modulators (SERMs) are widely prescribed drugs that alter cellular and whole-body cholesterol homeostasis. Here we evaluate the effect of SERMs on the macrophage-specific reverse cholesterol transport (M-RCT) pathway, which is mediated by HDL. Treatment of human and mouse macrophages with tamoxifen, raloxifene or toremifene induced the accumulation of cytoplasmic vesicles of acetyl-LDL-derived free cholesterol. The SERMs impaired cholesterol efflux to apolipoprotein A-I and HDL, and lowered ABCA1 and ABCG1 expression. These effects were not altered by the antiestrogen ICI 182,780 nor were they reproduced by 17β-estradiol. The treatment of mice with tamoxifen or raloxifene accelerated HDL-cholesteryl ester catabolism, thereby reducing HDL-cholesterol concentrations in serum. When [ 3 H]cholesterol-loaded macrophages were injected into mice intraperitoneally, tamoxifen, but not raloxifene, decreased the [ 3 H]cholesterol levels in serum, liver and feces. Both SERMs downregulated liver ABCG5 and ABCG8 protein expression, but tamoxifen reduced the capacity of HDL and plasma to promote macrophage cholesterol efflux to a greater extent than raloxifene. We conclude that SERMs interfere with intracellular cholesterol trafficking and efflux from macrophages. Tamoxifen, but not raloxifene, impair M-RCT in vivo. This effect is primarily attributable to the tamoxifen-mediated reduction of the capacity of HDL to promote cholesterol mobilization from macrophages.